Tag: focal therapy

Multiparametric MRI (mpMRI) has sparked a revolution in prostate cancer (PCa) detection, diagnosis and image-guided treatments. Transrectal ultrasound (TRUS) does not even begin to compare with the anatomic definition and tissue characterization provided by high-resolution, 3D mpMRI scans. This breakthrough technology has been a godsend for patients in such areas as Avoiding unnecessary needle biopsies keep reading

On a daily basis—probably far more than we are aware—we choose one thing or another based on how we perceive the information we have. This car is better than that car, this tomato is perfect but that tomato looks damaged, clean-shaven looks good on me but a beard looks bad. As an ancient metaphor puts keep reading

“In the 100 years from the mid-15th to the mid-16th century, a combination of circumstances stimulated men to seek new routes, and it was new routes rather than new lands that filled the minds of kings and commoners, scholars and seamen.”– Encyclopedia Britannica When the 15th century launched the Age of Discovery, it was actually keep reading

MRI-guided focused ultrasound is a new noninvasive focal treatment approach for localized low- and intermediate-risk prostate cancer. It has been in clinical study the in the U.S. for the past several years in order to evaluate its safety, effectiveness and side effect profile. The Sperling Prostate Center, along with eight other important medical centers, is keep reading

“Introducing the ultimate technology in Precision Medicine for Prostate Focal Therapy.” “TSPA is the only technology designed for Prostate Focal Therapy” These bold claims announce the availability of Tissue Sparing Prostate Ablation (TSPA), known by its brand name as Encage. Encage uses a specific type of radiofrequency ablation (RFA), which basically cooks a tumor by keep reading

Diagnosis of prostate cancer brings forth a mixed variety of feelings — from anger to disbelief to depression. To learn more about the condition and to be able to make an informed decision concerning diagnostic exams and treatments, it pays to ask questions.... keep reading

The Sperling Prostate Center is pleased to join seven academic centers in announcing the results of our national clinical trial of a novel focal prostate cancer treatment. keep reading

Did you ever take one of those whirlwind bus tours of Europe as a way to survey the best tourist attractions? Your itinerary might start by landing in London, then moving on to The Netherlands, Germany, Switzerland, Austria and Italy before your homeward bound departure. A July, 2021 published paper by Rakauskas, et al.[i] is keep reading

No one can dispute the superiority of multiparametric MRI (mpMRI) over transrectal ultrasound (TRUS) for detecting and characterizing prostate cancer (PCa) before biopsy and treatment. The past five years alone have seen a rapid accumulation of research evidence that mpMRI makes it possible to save medical dollars by avoiding unnecessary biopsies and their risks. While keep reading

A glance back in history reveals that not so many years ago, a prostatectomy to remove prostate cancer was a long and bloody surgery. It meant days in the hospital, a month of recovery, and higher rates of incontinence and ED than today’s robot-assisted laparascopic techniques. In comparison, today’s minimalist focal treatments for appropriate patients keep reading